Cystic Fibrosis Foundation
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$475.0M
Focus Areas
10
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| 4D Molecular Therapeutics | $475.0M |
| Carbon Biosciences | — |
| Owlstone Medical | — |